Novozymes A/S – (NVZMY) Downgraded by Zacks Investment Research to Sell
Novozymes A/S – (NASDAQ:NVZMY) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a report issued on Friday.
According to Zacks, “Novozymes A/S is primarily engaged in the development, production, and distribution of enzymes. Its business consists of two segments, enzyme business and bio business. The Company’s enzyme business segment offers detergent enzymes that are used in laundry and dishwashing, technical enzymes used in the transformation of starch into different kinds of sugars and have application in leather, textile, and forest product industries, food enzymes used in production of bread, wine, juice, beer, noodles, alcohol, and pasta and feed enzymes used in animal feed. Its bio business segment offers microorganisms that are used in industrial and municipal wastewater treatment, as well as in the cleaning of surfaces such as carpet, concrete, drain lines, and septic tanks in industrial and household applications. It also has application in the Biopharmaceutical ingredients used in pharmaceutical industry. Novozymes A/S is headquartered in Bagsvaerd, Denmark. “
NVZMY has been the topic of a number of other reports. Berenberg Bank began coverage on Novozymes A/S – in a report on Tuesday, September 27th. They issued a “sell” rating on the stock. Deutsche Bank AG began coverage on Novozymes A/S – in a report on Friday. They issued a “hold” rating on the stock.
This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at https://www.americanbankingnews.com/2016/10/07/novozymes-as-nvzmy-downgraded-by-zacks-investment-research-to-sell.html
Shares of Novozymes A/S – (NASDAQ:NVZMY) traded down 0.102% on Friday, hitting $43.995. The stock had a trading volume of 16,971 shares. The company has a 50-day moving average of $43.64 and a 200 day moving average of $46.07. Novozymes A/S – has a 52 week low of $37.98 and a 52 week high of $49.55. The company has a market capitalization of $13.22 billion and a price-to-earnings ratio of 30.616.
Novozymes A/S – Company Profile
Novozymes A/S is a Denmark-based biotechnology company engaged in the production and sale of industrial enzymes, microorganisms and biopharmaceutical ingredients. In June 2013, the Company restructured its sales areas within those segments. The Household Care (old Household Care Enzymes) area comprises cleaning solutions, laundry, dishwashing and microorganism sales for cleaning solutions.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Novozymes A/S - Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novozymes A/S - and related companies with MarketBeat.com's FREE daily email newsletter.